bioAffinity Technologies (BIAF) Current Assets (2021 - 2026)

bioAffinity Technologies (BIAF) has 6 years of Current Assets data on file, last reported at $4.3 million in Q1 2026.

• Current Assets for Q1 2026 came in at $4.3 million, up 132.94% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.3 million (up 132.94% YoY), and the FY2025 annual result was $7.6 million, up 180.7% from the prior year.
• Current Assets fell to $4.3 million in Q1 2026 per BIAF's latest filing, from $7.6 million in the prior quarter.
• Over five years, Current Assets peaked at $14.1 million in Q3 2022 and troughed at $1.7 million in Q2 2025.
• A 5-year average of $6.1 million and a median of $4.3 million in 2026 frame the typical range for Current Assets.
• The sharpest annual moves came in 2022 and 2024: Current Assets surged 731.69% in 2022, then sank 69.05% in 2024.
• A 5-year view of Current Assets shows it stood at $12.0 million in 2022, then tumbled by 66.79% to $4.0 million in 2023, then sank by 32.16% to $2.7 million in 2024, then jumped by 180.7% to $7.6 million in 2025, then tumbled by 42.61% to $4.3 million in 2026.
• Business Quant data shows BIAF's Current Assets at $4.3 million in Q1 2026, $7.6 million in Q4 2025, and $8.6 million in Q3 2025.